Novel Chemiluminescence Immunoassay (CLIA) for the Sensitive Determination of Kidney Injury Molecule-1 in Human Urine

References

• Ambar, A. M., F. Ameen, S. Al-Nadhari, A. Waseem, M. Yaqoob, A. A. Alarfaj, and A. Nabi. 2020. A flow injection chemiluminescence method for the determination of retinol in pharmaceutical formulations by using luminol-diperiodatoargentate(III) reaction. Journal of Nutritional Science and Vitaminology 66 (1):10–8. doi:10.3177/jnsv.66.10.
   PubMedGoogle Scholar
• Assadi, F, and F. G. Sharbaf. 2019. Urine KIM-1 as a potential biomarker of acute renal injury after circulatory collapse in children. Pediatric Emergency Care 35 (2):104–7.
   PubMed Web of Science ®Google Scholar
• Bonventre, J. V. 2009. Kidney injury molecule-1 (KIM-1): A urinary biomarker and much more. Nephrology, Dialysis, Transplantation: Official Publication of the European Dialysis and Transplant Association - European Renal Association 24 (11):3265–8. doi:10.1093/ndt/gfp010.
   PubMed Web of Science ®Google Scholar
• Chaturvedi, S., T. Farmer, and G. F. Kapke. 2009. Assay validation for KIM-1: Human urinary renal dysfunction biomarker. International Journal of Biological Sciences 5 (2):128–34.
   PubMed Web of Science ®Google Scholar
• Gunnerson, A. D., L. S. Shaw, A. Chawla, A. Bihorac, K. Al-Khafaji, M. Kashani, J. Lissauer, M. G. Shi, J. A. Walker, and Kellum, K. J, Sapphire Topaz investigators. 2016. TIMP2•IGFBP7 biomarker panel accurately predicts acute kidney injury in high-risk surgical patients. The Journal of Trauma and Acute Care Surgery 80 (2):243–9. doi:10.1097/TA.0000000000000912.
   PubMed Web of Science ®Google Scholar
• He, S., M. Yang, X. Wu, G. Cai, K. Jiang, and L. Xie. 2020. Comparison of a novel chemiluminescence immunoassay with the passive agglutination method for the diagnosis of mycoplasma pneumoniae infection in children. Journal of Microbiological Methods 173:105921. doi:10.1016/j.mimet.2020.105921.
   PubMed Web of Science ®Google Scholar
• Heise, D., K. Rentsch, A. Braeuer, M. Friedrich, and M. Quintel. 2011. Comparison of urinary neutrophil glucosaminidase-associated lipocalin, cystatin C, and α1-microglobulin for early detection of acute renal injury after cardiac surgery. European Journal of Cardio-Thoracic Surgery: Official Journal of the European Association for Cardio-Thoracic Surgery 39 (1):38–43. doi:10.1016/j.ejcts.2010.05.044.
   PubMed Web of Science ®Google Scholar
• Ichimura, T., J. V. Bonventre, V. Bailly, H. Wei, C. A. Hession, R. L. Cate, and M. Sanicola. 1998. Kidney injury molecule-1 (KIM-1), a putative epithelial cell adhesion molecule containing a novel immunoglobulin domain, is up-regulated in renal cells after injury. The Journal of Biological Chemistry 273 (7):4135–42. doi:10.1074/jbc.273.7.4135.
   PubMed Web of Science ®Google Scholar
• Jiang, Q. Q., M. F. Han, K. Ma, G. Chen, X. Y. Wan, S. B. Kilonzo, W. Y. Wu, Y. L. Wang, J. You, and Q. Ning. 2018. Acute kidney injury in acute-on-chronic liver failure is different from in decompensated cirrhosis. World Journal of Gastroenterology 24 (21):2300–10. doi:10.3748/wjg.v24.i21.2300.
   PubMed Web of Science ®Google Scholar
• Kaufmann, M., M. Schlossbauer, U. Hubauer, S. Stadler, M. Fischer, S. Wallner, J. Hupf, M. Zimmermann, E. Orso, F. Zeman, et al. 2020. N‐acety‐β‐D‐glucosaminidase: A potential biomarker for early detection of acute kidney injury in acute chest pain. Nephrology (Carlton, Vic.) 25 (2):135–43. doi:10.1111/nep.13664.
   PubMedGoogle Scholar
• Kidney Disease: Improving Global Outcomes Acute Kidney Injury Work Group. 2012. KDIGO clinical practice guideline for acute kidney injury. Kidney International Supplements. 2 (1):1.
   Google Scholar
• Kidney Disease: Improving Global Outcomes CKD Work Group 2013., KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease.
   Google Scholar
• Ležaić, V. 2010. Serum and urinary biomarkers determination and their significance in diagnosis of kidney diseases. Journal of Medical Biochemistry 29 (4):288–97. doi:10.2478/v10011-010-0046-3.
   Google Scholar
• Li, F., L. Guo, Y. Hu, Z. Li, J. Liu, J. He, and H. Cui. 2020. Multiplexed chemiluminescence determination of three acute myocardial infarction biomarkers based on microfluidic paper-based immunodevice dual amplified by multifunctionalized gold nanoparticles. Talanta 207:120346. doi:10.1016/j.talanta.2019.120346.
   PubMed Web of Science ®Google Scholar
• Lin, X., J. Yuan, Y. T. Zhao, and Y. Zha. 2015. Urine interleukin-18 in prediction of acute kidney injury: A systemic review and meta-analysis. Journal of Nephrology 28 (1):7–16. doi:10.1007/s40620-014-0113-9.
   PubMed Web of Science ®Google Scholar
• Liu, J., Y. Zhao, Z. Q. Li, Q. Chen, C. Q. Luo, J. X. Su, and Y. M. Wang. 2021. Biomarkers for detecting and improving AKI after liver transplantation: From diagnosis to treatment. Transplantation Reviews (Orlando, Fla.) 35 (2):100612. doi:10.1016/j.trre.2021.100612.
   PubMedGoogle Scholar
• Luyckx, V. A., Z. Al-Aly, A. K. Bello, E. Bellorin-Font, R. G. Carlini, J. Fabian, G. Garcia-Garcia, A. Iyengar, M. Sekkarie, W. Biesen, et al. 2021. Sustainable development goals relevant to kidney health: An update on progress. Nature Reviews. Nephrology 17 (1):15–32. doi:10.1038/s41581-020-00363-6.
   PubMedGoogle Scholar
• Marcovecchio, M. L., M. Colombo, R. N. Dalton, P. M. McKeigue, P. Benitez‐Aguirre, F. J. Cameron, S. T. Chiesa, J. J. Couper, M. E. Craig, D. Daneman, AdDIT and the SDRNT1BIO Investigators, et al. 2020. Biomarkers associated with early stages of kidney disease in adolescents with type 1 diabetes. Pediatric Diabetes 21 (7):1322–32., doi:10.1111/pedi.13095.
   PubMedGoogle Scholar
• Parikh, C. R., H. Thiessen-Philbrook, A. X. Garg, D. Kadiyala, M. G. Shlipak, J. L. Koyner, C. L. Edelstein, P. Devarajan, U. D. Patel, M. Zappitelli, TRIBE-AKI Consortium, et al. 2013. Performance of kidney injury molecule-1 and liver fatty acid-binding protein and combined biomarkers of AKI after cardiac surgery. Clinical Journal of the American Society of Nephrology: CJASN 8 (7):1079–88., doi:10.2215/CJN.10971012.
   PubMed Web of Science ®Google Scholar
• Rumpel, J., B. J. Spray, V. Y. Chock, M. J. Kirkley, C. L. Slagle, A. Frymoyer, S. H. Cho, K. M. Gist, R. Blaszak, B. Poindexter, et al. 2022. Urine biomarkers for the assessment of acute kidney injury in neonates with hypoxic ischemic encephalopathy receiving therapeutic hypothermia. The Journal of Pediatrics 241:133–40.e3. doi:10.1016/j.jpeds.2021.08.090.
   PubMedGoogle Scholar
• Schulz, C. A., G. Engström, J. Nilsson, P. Almgren, M. Petkovic, A. Christensson, P. M. Nilsson, O. Melander, and M. Orho-Melander. 2020. Plasma kidney injury molecule-1 (p-KIM-1) levels and deterioration of kidney function over 16 years. Nephrology, Dialysis, Transplantation: Official Publication of the European Dialysis and Transplant Association - European Renal Association 35 (2):265–73. doi:10.1093/ndt/gfy382.
   PubMed Web of Science ®Google Scholar
• Song, J., J. Yu, G. W. Prayogo, W. Cao, Y. Wu, Z. Jia, and A. Zhang. 2019. Understanding kidney injury molecule 1: A novel immune factor in kidney pathophysiology. American Journal of Translational Research 11 (3):1219–29.
   PubMed Web of Science ®Google Scholar
• Tirsa, T. van D, L. R. Ruhaak, C. van Kooten, J. W. de Fijter, and C. M. Cobbaert. 2022. Multiplex LC-MS/MS testing for early detection of kidney injury: A next-generation alternative to conventional immunoassays? The Journal of Applied Laboratory Medicine 7 (4):923–30. doi:10.1093/jalm/jfac024.
   PubMedGoogle Scholar
• Vaidya, V. S., V. Ramirez, T. Ichimura, N. A. Bobadilla, and J. V. Bonventre. 2006. Urinary kidney injury molecule-1: A sensitive quantitative biomarker for early detection of kidney tubular injury. American Journal of Physiology. Renal Physiology 290 (2):F517–F529. doi:10.1152/ajprenal.00291.2005.
   PubMed Web of Science ®Google Scholar
• Venkata, S., S. K. Ito, C. Wang, L. Yang, S. C. Mefferd, and J. V. Bonventre. 2013. Novel assays for detection of urinary KIM-1 in mouse models of kidney injury. Toxicological Sciences: An Official Journal of the Society of Toxicology 131 (1):13–25. doi:10.1093/toxsci/kfs268.
   PubMedGoogle Scholar
• Walther, C. P, and J. S. Benoit. 2021. Tubular kidney biomarker insights through factor analysis. American Journal of Kidney Diseases: The Official Journal of the National Kidney Foundation 78 (3):335–7. doi:10.1053/j.ajkd.2021.03.016.
   PubMedGoogle Scholar
• Wang, H., X. Zhai, T. Liu, J. Liang, L. Bian, L. Lin, Z. Chen, P. Li, Z. Dong, Z. Li, et al. 2019. Development of a novel immunoassay for the simple and fast quantitation of neutrophil gelatinase-associated lipocalin using europium(III) chelate microparticles and magnetic beads. Journal of Immunological Methods 470:15–9. doi:10.1016/j.jim.2019.04.004.
   PubMedGoogle Scholar
• Wang, R., H. Hu, S. Hu, H. He, and H. Shui. 2020. β2-microglobulin is an independent indicator of acute kidney injury and outcomes in patients with intracerebral hemorrhage. Medicine 99 (8):e19212. doi:10.1097/MD.0000000000019212.
   PubMedGoogle Scholar
• Yap, D. Y. H., W. K. Seto, J. Fung, S. H. Chok, S. C. Chan, G. C. W. Chan, M. F. Yuen, and T. M. Chan. 2017. Serum and urinary biomarkers that predict hepatorenal syndrome in patients with advanced cirrhosis. Digestive and Liver Disease: Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver 49 (2):202–6. doi:10.1016/j.dld.2016.11.001.
   PubMedGoogle Scholar
• Zdziechowska, M., A. Gluba-Brzózka, A. R. Poliwczak, B. Franczyk, M. Kidawa, M. Zielinska, and J. Rysz. 2020. Serum NGAL, KIM-1, IL-18, L-FABP: New biomarkers in the diagnostics of acute kidney injury (AKI) following invasive cardiology procedures. International Urology and Nephrology 52 (11):2135–43. doi:10.1007/s11255-020-02530-x.
   PubMed Web of Science ®Google Scholar
• Zhang, J., N. Li, W. Guo, C. Ma, and G. Zhao. 2018. Diagnostic value of urinary microalbumin level in postpartum acute kidney injury. Iranian Journal Public Health 47 (3):367–72.
   PubMedGoogle Scholar
• Zhang, P. L., J. W. Mashni, V. S. Sabbisetti, C. M. Schworer, G. D. Wilson, S. C. Wolforth, K. M. Kernen, B. D. Seifman, M. B. Amin, T. J. Geddes, et al. 2014. Urine kidney injury molecule-1: a potential non-invasive biomarker for patients with renal cell carcinoma. International Urology and Nephrology 46 (2):379–88. doi:10.1007/s11255-013-0522-z.
   PubMed Web of Science ®Google Scholar
• Zheng, S. X., X. M. Zhou, Q. Yuan, X. M. Yu, L. L. Chen, X. B. Liu, Y. G. Wang, J. G. Gong, S. J. Shen, and B. Huang. 2022. Establishment of a time-resolved immunoassay for acute kidney injury based on the detection of Kim-1. Journal of Clinical Laboratory Analysis 36 (9):e24603. doi:10.1002/jcla.24603.
   PubMedGoogle Scholar